Regeneron and Sanofi Announce Publication of Positive Phase 2 Dupilumab Data in the Journal of the American Medical Association

You are now leaving Investor.Regeneron.com. The site you are about to visit is maintained by a third party who is solely responsible for its content. We encourage you to read the privacy policy of every website you visit.

Continue

Release Details

Regeneron and Sanofi Announce Publication of Positive Phase 2 Dupilumab Data in the Journal of the American Medical Association